Christopher Shutts

Angel investor in Libertyville

Invests in AI

Christopher Shutts's investor profile lists AI alongside Healthcare & Biotech, SaaS & Enterprise and Consumer & Retail, at early-stage venture. The record holds 2 deals, among them UltraSource LLC and G2.com.

Email Investor

Email Investor

Credits to line up before an early-stage round

Christopher Shutts backs companies at early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • UltraSource LLC
  • G2.com

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, SaaS & Enterprise, Consumer & Retail, Developer Tools & Data, Cybersecurity and 4 more
Rounds
Early-stage venture
Profile
Angel investor
Deals on record
2
Based in
Libertyville, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Christopher Shutts invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Christopher Shutts's investor profile, together with Healthcare & Biotech, SaaS & Enterprise and Consumer & Retail. The stages on record are early-stage venture.
Which companies has Christopher Shutts backed?
The record lists 2 deals, including UltraSource LLC and G2.com. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Christopher Shutts?
For a company raising an early-stage round, AI Perks lists credits such as Confluent (up to $20,000), Weaviate (up to $100,000), Google Cloud (up to $350,000) and Aiven (up to $100,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor